Sinco Pharmaceuticals Holdings Limited (HKG:6833)
0.1880
+0.0100 (5.62%)
At close: Mar 27, 2026
HKG:6833 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 249.2 | 308.32 | 437.92 | 329.14 | 326.05 |
Cash & Short-Term Investments | 249.2 | 308.32 | 437.92 | 329.14 | 326.05 |
Cash Growth | -19.18% | -29.59% | 33.05% | 0.95% | 126.79% |
Accounts Receivable | 591.57 | 608.25 | 540.51 | 351.27 | 213.6 |
Other Receivables | - | 73.14 | 51.88 | 37.74 | 10.35 |
Receivables | 591.57 | 681.39 | 592.38 | 389.01 | 223.96 |
Inventory | 259.56 | 352.53 | 108.03 | 89.58 | 62.76 |
Prepaid Expenses | - | - | - | - | 1.3 |
Restricted Cash | - | 103.06 | 220.03 | 107.85 | 55.02 |
Other Current Assets | 254.34 | 66.91 | 74.93 | 101.82 | 299.9 |
Total Current Assets | 1,355 | 1,512 | 1,433 | 1,017 | 968.98 |
Property, Plant & Equipment | 359.1 | 371.36 | 354.21 | 315.84 | 256.26 |
Goodwill | 66.54 | 66.54 | 66.54 | 66.54 | - |
Other Intangible Assets | 56.65 | 11.81 | 14.03 | 15 | - |
Long-Term Deferred Tax Assets | 4.2 | 2.42 | 3.4 | 3 | 0.86 |
Long-Term Deferred Charges | - | 30.14 | 13.08 | - | - |
Other Long-Term Assets | 5.78 | 5.96 | 6.14 | 6.55 | 6.67 |
Total Assets | 1,847 | 2,000 | 1,891 | 1,424 | 1,233 |
Accounts Payable | 912.22 | 887.97 | 866.59 | 407.99 | 422.93 |
Accrued Expenses | - | 14.67 | 17.13 | 86.11 | 17.49 |
Short-Term Debt | - | 340 | 240 | 180.81 | 207.51 |
Current Portion of Long-Term Debt | 179.72 | 0.86 | 0.86 | - | 0.81 |
Current Portion of Leases | 3.19 | 5.14 | 3.83 | 3 | 0.38 |
Current Income Taxes Payable | 17.13 | 20.59 | 26.44 | 5.44 | 12.83 |
Current Unearned Revenue | 18.85 | 27.73 | 40.46 | 75.43 | 27.75 |
Other Current Liabilities | 20.38 | 34.7 | 36.73 | 31.82 | 35.93 |
Total Current Liabilities | 1,151 | 1,332 | 1,232 | 790.59 | 725.64 |
Long-Term Debt | - | 0.05 | 0.89 | 0.92 | 132.24 |
Long-Term Leases | 0.49 | 4.49 | 5.83 | 7.69 | - |
Long-Term Deferred Tax Liabilities | 0.9 | 1.35 | 1.8 | 2.25 | - |
Other Long-Term Liabilities | - | - | 22.08 | 19.08 | - |
Total Liabilities | 1,153 | 1,338 | 1,263 | 820.52 | 857.88 |
Common Stock | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 |
Additional Paid-In Capital | - | 529.48 | 529.48 | 529.48 | 370.02 |
Retained Earnings | - | 133.24 | 98.41 | 74.17 | 0.48 |
Comprehensive Income & Other | 693.9 | - | - | - | 4.23 |
Total Common Equity | 694.06 | 662.88 | 628.05 | 603.81 | 374.89 |
Shareholders' Equity | 694.06 | 662.88 | 628.05 | 603.81 | 374.89 |
Total Liabilities & Equity | 1,847 | 2,000 | 1,891 | 1,424 | 1,233 |
Total Debt | 183.39 | 350.54 | 251.4 | 192.41 | 340.95 |
Net Cash (Debt) | 65.81 | -42.22 | 186.52 | 136.73 | -14.9 |
Net Cash Growth | - | - | 36.41% | - | - |
Net Cash Per Share | 0.03 | -0.02 | 0.09 | 0.07 | -0.01 |
Filing Date Shares Outstanding | 2,067 | 2,033 | 2,033 | 2,033 | 1,873 |
Total Common Shares Outstanding | 2,067 | 2,033 | 2,033 | 2,033 | 1,873 |
Working Capital | 203.18 | 180.55 | 201.25 | 226.82 | 243.34 |
Book Value Per Share | 0.34 | 0.33 | 0.31 | 0.30 | 0.20 |
Tangible Book Value | 570.87 | 584.53 | 547.49 | 522.28 | 374.89 |
Tangible Book Value Per Share | 0.28 | 0.29 | 0.27 | 0.26 | 0.20 |
Buildings | - | 214.5 | 196.87 | 197.31 | 197.31 |
Machinery | - | 58.89 | 25.98 | 22.94 | 20.06 |
Construction In Progress | - | 68.04 | 107.3 | 84.58 | 33.5 |
Leasehold Improvements | - | 36.32 | 13.67 | 11.19 | 11.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.